Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose- dependent protective effect of a platelet-activating factor receptor antagonist

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 786-794

  Riera, M ^b   Torras, J ^a   Herrero, I ^b   Valles, J ^a   Paubert Braquet, M ^d   Cruzado, J M ^a   Alsina, J ^a   Grinyo, J M ^a,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d BIO Inova EuroLab Research Labs   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGOLIDE B; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; ISOLATED KIDNEY; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SODIUM ABSORPTION;

ANIMALS; COLD; DITERPENES; FIBRINOLYTIC AGENTS; GINKGOLIDES; GLOMERULAR FILTRATION RATE; GLUCOSE; HUMANS; HYPERTONIC SOLUTIONS; KIDNEY; LACTONES; MALE; NEUTROPHILS; ORGAN PRESERVATION; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; REPERFUSION INJURY; TROMETHAMINE; VASCULAR RESISTANCE;

EID: 0030899606     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. ADAMS, D. AND SHAW, S.: Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343: 831-836, 1994.
2. ALLOATI, G., MONTRUHIO, G. AND CAMUSI, G.: Role of platelet-activating factor (PAF) in oxygen radical induced cardiac dysfunction. J. Pharmacol. Exp. Ther. 269: 766-771, 1994.
3. ARNOULD, T., MICHIELS, C. AND REMACLE, J.: Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD18/CD11b, and ICAM-1. Am. J. Physiol. 264: C1102-C1110; 1993.
4. BAILLY, C., BARLET-BAS, C. AND AMIEL, C.: Platelet-activating factor inhibits Cl and K transport in the medullary thick ascending limb. Kidney Int. 41: 269-274, 1992.
5. BEDNAR, M. M., KRAEMER, R., ABRAHAM, N. G. AND MULLANE, K. M.: Arachidonic acid monooxygenase and lipoxygenase activities in polymorphonuclear leukocytes. Biochem. Pharmacol. 36: 1741-1747, 1987.
6. BIENVENU, K. AND GRANGER, D. N.: Leukocyte adhesion in ischemia/reperfusion. Blood Cells 19: 279-289, 1993.
7. CLAVIEN, P. A., HARVEY, R. C. AND STRASBERG, S. M.: Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53: 957-978, 1992.
8. CONTE, J. V., KATZ, N. M., WALLAGE, R. B. AND FOEGH, M. L.: Long-term lung preservation with the PAF antagonist BN 52021. Transplantation 51: 1152-1156, 1991.
9. DEBY-DUPONT, G., ETIENNE, E., BRAQUET, P., BOURBON-NUERAY, J. AND GOUTIER, R.: Effect of Ginkgolide B (BN 52021) on the enzymatic activity of bovine and human trypsins. Arch. Int. Physiol. Biochem. 94: 7P-8P, 1986.
10. GERKENS, J. F.: Reproducible vasodilatation by platelet-activating factor in blood and Krebs perfused rat kidneys is albumin dependent. Eur. J. Pharmacol. 177: 119-126, 1990.
11. GRINYO, J. M., FOR THE BN 52021 STUDY GROUP IN RENAL TRANSPLANTATION: BN 52021, a platelet activating factor antagonist, to prevent post-transplant renal failure. Ann. Intern. Med. 121: 345-347, 1994.
12. HANDLEY, D. A. AND SAUNDERH, R. N.: Platelet activating factor and inflammation in atherogenesis: Targets for drug development. Drug Dev. Res. 7: 361-375, 1986.
13. HANSEN, P. R.: Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91: 1872-1885, 1995.
14. HEBERT, R. L., SIROIS, P. AND PLANTE, G. E.: Inhibition of platelet-activating factor induced renal hemodynamic and tubular dysfunctions with L-655-240, a new thromboxane-prostaglandin endoperoxide antagonist. Can. J. Physiol. Pharmacol. 67: 304-308, 1989.
15. HENRI BEAUFOUR INSTITUTE: BN 52021. Investigators brochure, pp. 47-51, 1993.
16. HERRERO, I., TORRAS, J., CASTELLS, A., CARRERA, M., PASTO, L., GIL-VERNET, S., ALSINA, J. AND GRINYO, J. M.: Evaluation of a preservation solution containing fructose-1,6-diphosphate and mannitol using the isolated perfused rat kidney. Comparison with Euro-Collins and University of Wisconsin solutions. Nephrol. Dial. Transp. 10: 519-526, 1995.
17. HOGG, N.: Roll, roll, roll your leucocyte gently down the vein. Immunol Today 13: 113-115, 1992.
18. IMATZUMI, T., STAFORINI, D. M., YAMADA, Y., MCINTYRE, TH. M., PRESCOTT, S. M. AND ZIMMERMAN, G. A.: Platelet-activating factor: A mediator for clinicians. J. Intern. Med. 238: 5-20, 1995.
19. JUNCOS, L. A., REN, Y. L., ARIMA, S. AND ITO, S: Vasodilator and constrictor actions of platelet activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxigenase products. J. Clin. Invest. 91: 1374-1379, 1993.
20. KENZORA, J., PEREZ, J., BERGMANN, S. AND LANGE, L.: Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. J. Clin. Invest. 74: 1193-1199, 1984.
21. KO, W., LANG, D., HAWES, A. S., ZELANO, J. A., ISOM, O. W. AND KRIEGER, K. H.: Platelet activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. J. Surg. Res. 55: 504-515, 1993.
22. KUBES, P., IBBOTSON, G., RUSSELL, J., WALLACE, J. L. AND GRANGER, D. N.: Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am. J. Physiol. 259: G300-G305, 1990.
23. LEFER. A. M., MA, X.-L., MEYRICH. A. S. AND SCALIA, R.: Mechanism of the cardioprotective effect of transforming growth factor B1 in feline myocardial ischemia and reperfusion. Proc. Natl. Acad. Sci. U.S.A. 90: 1018-1022, 1993.
24. LEFER, A. M. AND LEFER, D. J.: Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu. Rev. Pharmacol. Toxicol. 33: 71-90, 1993.
25. LEWIS, M. S., WHATLEY, R. E., CAIN, P., MCINTYRE, T. M., PRESCOTT, S. M. AND ZIMMERMAN, G. A.: Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J. Clin. Invest. 82: 2045-2055, 1988.
26. 2 metabolites cause reperfusion injury after short but not prolonged renal ischemia. Am. J. Physiol. 253: F685-F691, 1987.
27. LINAS, S. L., SHANLEY, P. F., WHITTENBURG, D., BERGER, E. AND REPINE, J. E.: Neutrophils accentuate ischemic-reperfusion injury in isolated perfused rat kidneys. Am. J. Physiol. 255: F728-F735, 1988.
28. LINAS, S. L., WHITTENBURG, D., PARSONS, P. E. AND REPINE, J. E.: Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int. 42: 610-616, 1992.
29. LOPEZ-FARRE, A., TORRALBO, M. AND LOPEZ NOVOA, J. M.: Glomeruli from ischemic rat kidneys produce inreased amounts of platelet-ativating factor. Biochem. Biophys. Res. Commun. 152: 129-135, 1988.
30. LOPEZ-FARRE, A., BERNABEU, F., GOMEZ-GARRE, D., RAMON Y CAJAL, S., BRAQUET P. AND LOPEZ NOVOA, J. M.: Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats. J. Pharmacol Exp. Ther. 253: 328-333, 1989.
31. LOTNER, G. Z., LYNCH, J. M., BETZ, S. J. AND HENSON, P. M.: Human neutrophil derived platelet activating factor. J. Immunol. 124: 676-684, 1980.
32. MA, X. I., TSAO, P. S. AND LEFER, A. M.: Antibody to CD 18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion J. Clin. Invest. 88: 1237-1243, 1991.
33. MA, X. I., WEYRICH, A. S., KRANTZ, S. AND LEFER, A. M.: Mechanisms of the cardioprotective ations of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ishemia and reperfusion. J. Pharmacol. Exp Ther 260: 1229-1235, 1992.
34. MARZI, I., WALCHER, F., MENGER, M., BÜHREN, V., HARBAUER, G. AND TRENTZ, O.: Microcirculatory disturbances and leucocyte adherence in transplanted livers after cold storage in Euro-Collins, UW and HTK solutions. Transplant. Int. 4: 45-50, 1991.
35. MILHOAN, K. A., LANE, T. A. AND BLOOR, C. M.: Hypoxia induces endothelial cells to increase their adherence for neutrophils: Role of PAF. Am. J. Physiol 263: H956-H962, 1992.
36. MONTRUCCHIO, G., ALLOATI, G., TETTA, C., DELUCA, R., SAUNDERS, R. N., EMANUELLI, G. AND CAMUSSI, G.: Release of platelet-activating factor from ischemic-reperfused rabbit heart. Am. J. Physiol. 256: H1236-H1242, 1989.
37. MORESO, F., GALLÉN, M., GARCÍA-OSUNA, R., TORRAS, J., GIL-VERNET, S., CASTELAO, A. M., SERÓN, D., CRUZADO, J. M. AND GRINYÓ, J. M.: Multivariate analysis of prognostic factors in renal transplantation. Transplant. Proc. 27: 2226-2228, 1995.
38. NISHIYAMA, R., NAKAMURA, S., SUZUKI, S. AND BABA, S.: Platelet activating factor in hepatic ischemia-reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue. Transplantation 55: 1261-1265, 1993.
39. ONTELL, S. J., MAKOWKA, L., OVE, P. AND STARZL, T. E.: The effects of a platelet activating factor antagonist on post ischemic hepatic function in the rat. Surg. Forum 38: 388-389, 1987.
40. ONTELL, S. J., MAKOWKA, L., OVE, P. AND STARZL, T. E.: Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441. Gastroenterology 95: 1617-1624, 1988.
41. PIROTZKI, E., NINIO, E., BIDAULT, J., PFISTER, A. AND BENVENISTE, J.: Biosynthesis of platelet activating factor. Lab. Invest. 5: 567-572, 1984.
42. RASCHKE, P. AND BECKER, B. F.: Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischemia. Cardiovasc. Res. 29: 569-576, 1995.
43. READ, R. A., MOORE, E. E., MOORE, F. A., CARL, V. S. AND BANERJEE, A.: Platelet activating factor-induced polymorphonuclear neutrophil priming independent of CD 11b adhesion. Surgery 114: 308-313, 1993.
44. SALINAS, P., PEREZ, M. D., FERNANDEZ-SAN PABLO, R., FERNANDEZ-GALLARDO, S., SANCHEZ-CRESPO, M. AND BARRIGÓN, S.: Lack of platelet-activating factor release on acute myocardial ischemia in the isolated interventricular septum of rabbit heart. Eur. J. Pharmacol, 293: 65-70, 1995.
45. SCHMIDT, F. H.: Die enzymatische Bestimmung von Glukose und Fruktose nebeneinander. Klin. Wochenschr. 39: 1244-1247, 1961.
46. SCHUREK, H. J. AND ALT, J. M.: Effect of albumin on the function of perfused rat kidney. Am. J. Physiol. 240: F569-F576, 1981.
47. STAHL, G. L., TERASHITA, Z. I. AND LEFER, A. M.: Role of platelet activating factor in propagation of ardiac damage during myocardial ischemia. J. Pharmacol. Exp. Ther. 244: 898-904, 1988.
48. SUGIURA, T. AND WAKU, K.: Composition of alkyl ether-linked phospholipids in mammalian tissues. In Platelet-activating factor and related lipid mediators, ed. by F. Snyder, pp. 55-61, Plenum Publishing Corp., New York, NY, 1987.
49. SUZUKI, S. H., TOLEDO-PEREYRA, L. H., RODRIGUEZ, F. J. AND CEJALVO, D: Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and Cyclosporine. Transplantation 55: 1265-1272, 1993.
50. TAYLOR, J. E., SCOTT, N., HILL, A., BRIDGES, A., HENDERSON, I. S., STEWART, W.K. AND BELCH, J. J.: Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients. Transplantation 55: 500-504, 1993.
51. TORRAS, J., BORDALBA, J. R., SERON, D., MOLINER, R., CARRERA, M., VALLES, J., MARTINEZ CASTELAO, A., ALSINA, J. AND GRINYO, J. M.: Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model. Transplant. Int. 6: 236-238, 1993.
52. WEDMORE, C. V. AND WILLIAMS, T. J.: Control of vascular permeability by PMN leukocytes in inflammation. Nature 289: 646-650, 1981
53. ZIMMERMAN, G. A., MCINTYRE, T. M. AND PRESCOTT, S. M.: Endothclial cell-associated platelet activating factor: A novel mechanism for signaling intercellular adhesion. J. Cell Biol. 110: 529-540, 1990.
54. ZIMMERMAN, G. A., PRESCOTT, S. M. AND MCINTYRE, T. M.: Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol. Today 13: 93-100, 1992.